Applying the Algorithms Case 1 Traveling Professional with Newly Diagnosed T2DM and Comorbid Conditions A 52-year-old man with a history of hypertension was recently diagnosed with T2DM at a yearly health screening offered through his employer for renewal of his medical and prescription coverage
GLP-1 Receptor Activation Metabolic Regulation GLP2 activates GLP-1 receptors with lower potency than endogenous GLP-1 but demonstrates biased signaling properties: Preferential cAMP pathway activation over beta-arrestin recruitment, which may enhance insulin secretory responses Suppression of inappropriately elevated glucagon secretion during hyperglycemia Reduced GLP-1 receptor internalization compared to native GLP-1, potentially extending signaling duration Contribution to glucose-dependent insulin secretion complementary to GIP receptor effects Research in isolated pancreatic islets demonstrated that GLP2s insulinotropic actions depend on GIP receptor presence, with the biased GLP-1 receptor signaling providing synergistic enhancement
Gastrointestinal symptoms beyond nausea warrant detailed tracking
With the increasing number of brands of L-Glutathione tablets, selecting the best product can be challenging for healthcare professionals, consumers, and distributors
The SURPASS program (multiple trials, NEJM and Lancet 2021 to 2022) supports the Mounjaro diabetes label
